Medical Devices

Surat’s New Civil Hospital to produce its own oxygen, Health News, ET HealthWorld

Surat: The New Civil Hospital (NCH) in Surat will now be producing its own oxygen which is likely to reduce its dependence on outside resources. As the Diamond City grapples with a shortage of infrastructure and resources to deal with Covid-19 crisis, the 2 kilo-litre pressure swing adsorption (PSA) plant at NCH will help ease pressure on the government hospital. This plant is probably the first in the state, out of the sanctioned four, to begin functioning.

After testing, the plant has been functional since the last two days and the oxygen supply is being used for the patients. Total 162 plants were recently sanctioned by the government of India to be installed at government hospitals across the country.

The PSA technology separates oxygen from the air and can be used for medical purposes. “The technology is widely in use but for the first time, such a plant has been installed here. The oxygen produced will help NCH meet the current demand and also help in future,” said Yogesh Chaudhary, in-charge of NCH. Chaudhary, an IAS officer, was recently posted as managing director, Dakshin Gujarat Vij Company Limited (DGVCL).

Currently, NCH has three oxygen storage plants, once each at Covid-19 hospital, New Kidney hospital which has also been converted into a Covid-19 hospital, and the old NCH building. On average NCH’s required around 60 tonnes of oxygen.

While the Surat civic body run SMIMER hospital has one oxygen storage plant and another is under development. SMIMER’s daily average consumption is around 26 tonnes.

“There is no shortage of oxygen at present and we are smoothly meeting the demand. In case of increased demand in future, there will not be a shortage,” said Prashant More, the owner of A D More & Sons, who manages the oxygen supply to the government hospitals.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Ad Block Detected

Welcome to Mediexpose, Please support our journalism by allowing ads. With support from readers like you, we can continue to deliver the best. You can support us free by simply allowing ads.